Authors


Jason Harris

Latest:

FDA Fast Tracks BCMA-Targeted CAR T-Cell Therapy for R/R Multiple Myeloma

The FDA has granted a fast track designation to CB-011, a CRISPR-edited allogeneic CAR T-cell therapy developed by Caribou Biosciences, for the treatment of patients with relapsed/refractory multiple myeloma.


Christopher M. Whinney, MD

Latest:

The Relationship Between the Follow-up to Discharge Ratio and Length of Stay

The objective was to evaluate the correlation between the follow-up to discharge ratio and average length of stay.


Maulik Majmudar, MD

Latest:

Long-Term Consequences of Arrhythmias

Experts discuss the complex clinical and economic challenges of atrial fibrillation, emphasizing the need for personalized care that balances symptom management, stroke prevention, and risk factor control—while recent evidence on subclinical atrial fibrillation highlights the limitations of widespread anticoagulation, reinforcing the importance of targeted, value-based strategies for optimal outcomes.


Charles Maynard, PhD, MSW

Latest:

Factors Associated With Primary Care Physician Turnover in the VA

This longitudinal observational study found higher team satisfaction with workload to be significantly associated with lower primary care physician turnover.


Mitch Perry

Latest:

Contributor: For Better or Worse, Inflation Isn’t New to Health Insurers

In this column, a health insurance executive discusses 2 ways to address rising inflation, including moving past the traditional fee-for-service payment model.


Ryan Scott

Latest:

Neoadjuvant KN026 Plus Docetaxel Demonstrate Early Activity in HER2+ Breast Cancer

A combination of KN026, a novel bispecific antibody, and docetaxel elicited responses with an acceptable toxicity profile when administered as neoadjuvant treatment in patients with HER2-positive (HER2+) early or locally advanced breast cancer.


Ryan Nguyen, PharmD, BCPS

Latest:

Pharmacist-Led Review of Empagliflozin and Ertugliflozin Following Formulary Update

Management of empagliflozin and ertugliflozin may be suboptimal following an insurance carrier’s formulary updates. Pharmacists may improve the management.


Portia J. Zaire, PhD, RN

Latest:

Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.


Jaehyeon Yun, PhD

Latest:

Predicting Hospital Readmission in Medicaid Patients With Diabetes Using Administrative and Claims Data

A statistical model based entirely on claims data can accurately predict 30-day hospital readmission in Medicaid patients with diabetes.


Scott E. Regenbogen, MD, MPH

Latest:

Hospital Strategies in Commercial Episode-Based Reimbursement

This study reports qualitative findings from an explanatory sequential mixed-methods investigation to understand hospitals’ approaches to a novel commercial episode-based reimbursement incentive program.


Seth Killion, BS

Latest:

Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration

A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.



Grazia Aleppo, MD

Latest:

The Role of Advanced Technologies in Improving Diabetes Outcomes

This article reviews underlying barriers to health care access and discusses how a value-based diabetes care model could improve patient outcomes and reduce long-term costs.




Dennis G. Maki, MD

Latest:

COVID-19 Control in the United States: The Case for Masking

In the control of COVID-19, the future perfect of the vaccine should not be the enemy of the present good, which is masking.


Ryan Flinn

Latest:

How In Vivo CAR T-Cell Therapies Could Rewrite the Cancer Care Playbook

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing financial toxicity and logistical barriers.


Marta Fiocco, PhD

Latest:

Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification Tool

In this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.


Lynda Charters

Latest:

ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment Days

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.


Kierstin Catlett, PhD

Latest:

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.


Mohamed I. Elsaid, PhD, MPH

Latest:

A Case-Control Study of Length of Stay Outliers

Length of stay outliers are associated with hospital-acquired infections, complications, and discharge to facility, as opposed to nonmodifiable risk factors like age and comorbidities.


Maritza Suarez, MD

Latest:

Social Determinants of Health Score: Does It Help Identify Those at Higher Cardiovascular Risk?

Calculating a social score is feasible and it predicts cardiovascular outcomes. In order to do this, institutions have to collect social determinants of health.


Garth Walker, MD, MPH

Latest:

Factors Associated With Unplanned Admissions Among Patients With Chronic Conditions

This study identified risk factors for unplanned admissions among patients with multiple chronic conditions to inform focused interventions.



Ruth Torreblanca, PhD

Latest:

Management of Procalcitonin Test Overuse in an Emergency Department Through a Computer Algorithm

Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.


Jordyn Newcome, MBA

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


David S. Krause, MD

Latest:

Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy Population

The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.


Allyson W. O’Connor, MPH

Latest:

Changes in Electronic Notification Volume and Primary Care Provider Burnout

Primary care provider burnout was analyzed before and after a national initiative to optimize the electronic health record inbox notification system at the Veterans Health Administration.



Helen M. Parsons, PhD

Latest:

Real-World Digitally Based Diabetes Management Program Implementation by a Large Employer

This study offers new insights to self-insured employers and health plans related to investment in digitally based disease management programs and enrollee engagement.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo